Skip to content

Mindfulness Training for Smoking Cessation

Examining the Effects of Brief Mindfulness Training on Smoking Quit Attempts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05440903
Enrollment
213
Registered
2022-07-01
Start date
2020-12-08
Completion date
2023-05-31
Last updated
2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Mindfulness, Meditation

Brief summary

Participants will complete this study remotely, either at home or at their preferred location using an online platform. The investigators propose to test the effects of a mindfulness training \[MT: Headspace\] intervention compared to a time and attention psycho-education control \[control: TedTalks\] among N=200 adult smokers of a nicotine product. Previous studies suggest that mindfulness training may be beneficial in reducing craving during tobacco abstinence. During the study, participants will complete baseline questionnaires, followed by two weeks of daily MT or control training and self-report on questionnaires assessing affect, cognition, and smoking behavior using Ecological Momentary Assessment (EMA) for remote data capture. Following this two weeks of training, participants will complete a smoking quit attempt and complete daily EMA questionnaires for two weeks. The first day of the smoking quit attempt will include a remote Zoom video session following overnight smoking abstinence. During this session the participants will complete a remote stressor task (Trier Social Stress Test, TSST), and the investigators will collect EMA data on affect and smoking behavior before and after the TSST. One month after the start of the quit attempt, participants will complete a phone call as a follow-up to assess smoking behavior over the previous 30 days, and to complete a debriefing. Study objectives are to test the effect of MT on: (1) smoking lapses during the follow-up periods; and (2) stress (affect, smoking urge, withdrawal symptoms) during the TSST.

Interventions

BEHAVIORALHeadspace

A smartphone application that provides users with mindfulness and meditation sessions.

BEHAVIORALTEDTalk

A smartphone application that provides users with psychoeducational audio recordings from TEDTalk.

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The investigators and majority of study staff are blinded. The only individuals who are unblinded to a participant's conditions do not conduct data collection nor interact with participants beyond assigning participants to a condition and explaining the protocol for MT or control app training. Participants are aware of their condition, but do not know that the protocol is being measured as the variable of interest, nor that other participants are assigned to different conditions.

Intervention model description

Between-groups study design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Smoke at least 5 cig/day for the past year * English fluency * Motivation to quit smoking in next 30 days, or willing to make a practice quit attempt * Reside in California * Have remote video capability (i.e., computer, laptop, tablet with working camera and audio) in order to complete all data collection procedures (Note that the study does not have resources to provide these materials) * Have working smartphone capable of downloading the app for EMA assessments

Exclusion criteria

* Current use of any nicotine replacement products (i.e., nicotine patch, gum, lozenge) or smoking cessation medications (i.e., Chantix, Bupropion, Wellbutrin, Zyban) * Current mindfulness or meditation practice of greater than 5 minutes each day.

Design outcomes

Primary

MeasureTime frameDescription
Smoking Cessation Behavior at 14 days14 days after start of quit attempt7-day point prevalence abstinence (i.e., no cigarettes smoked in the previous 7 days). 0=did not smoke; 1=smoked at least one cigarette.
Smoking Cessation Behavior at 30 days30 days after start of quit attempt7-day point prevalence abstinence (i.e., no cigarettes smoked in the previous 7 days). 0=did not smoke; 1=smoked at least one cigarette.

Secondary

MeasureTime frameDescription
Stress-related feelings of anxious1 min before the Trier Social Stress Test (TSST), and +5, +30, +60 min after TSSTvisual analog scales of I feel anxious using the scale (0=not at all to 100=extremely). A higher number indicates greater feelings of anxious
Stress-related feelings of relaxed1 min before the Trier Social Stress Test (TSST), and +5, +30, +60 min after TSSTvisual analog scales of I feel relaxed using the scale (0=not at all to 100=extremely). A higher number indicates greater feelings of relaxed
Cessation Motivationbaseline (start of the study) and 30 days after start of quit attemptchange in motivation to quit (or stay quit) as measured by the Contemplation Ladder, a visual graphic used to select current level of quit motivation (0=no thought of quitting; 10=taking action to quit). A higher number indicates greater motivation to quit smoking.
Stress-related feelings of urge to smoke1 min before the Trier Social Stress Test (TSST), and +5, +30, +60 min after TSSTvisual analog scales of I have an urge to smoke using the scale (0=not at all to 100=extremely). A higher number indicates greater feelings of urge to smoke
Stress-related feelings of stressed1 min before the Trier Social Stress Test (TSST), and +5, +30, +60 min after TSSTvisual analog scales of I feel stressed using the scale (0=not at all to 100=extremely). A higher number indicates greater feelings of stressed
App training adherence14 days after starting app trainingAdherence to app use will be calculated as the number of times an individual used the app out of a total of 28 sessions (2 session per day for 14 days). A higher number indicates better adherence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026